{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-13T12:24:19.559988+00:00",
  "news": [
    {
      "title": "The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZjBOblp5SzRrVlRSaFJDSDRZX2M0X3BJdXgyVGEwVHJJUVNnbHJra2hBTTFSLVZFeVpfbFI2N1pPYVo3UkU2ZEVZRUdmdWdDdGhTcHd2MkhMTElYOFNUM2lWOHMzd1lvUFlWNHF2NDNMWU9VMFVuQ3hZbFRLdjVVNTlqd1VyZnJKa1Zr?oc=5\" target=\"_blank\">The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-11T02:16:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5\" target=\"_blank\">Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-10-27T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals' (NASDAQ:VRTX) Performance Is Even Better Than Its Earnings Suggest - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPRmIzOWNqVDFGUVZyWHhGT3B5b2RJQTBVQ3dnVHVqcEF6dWNIRy1VR1BzUmdtd1ZtMGlvOEVyYTU4VXpvdzBtWlZ2QktSd0l2MzRLYlRLbS14ODhUdzVuOHZSZXZ3S3Vmd0Eyems0LUVBRWRzVlRzMTNSRE1TZ1NmWkZCZ1RkOXlUbUR1OGYyQXZqUDRFY3FjUm4tLU8zY2xjZHctMlV2d2pDVGp6dXpWSWs0X3cxZGhJRFhJQV9ZUEJoYzU3b3hxWVF1WG1fckxhRmVXbksxWHZWZ1pveDBsMk42bzMxNy1UNU9WU9IB8gFBVV95cUxQZEt6T3poOTY3NjduZ2h3WUxzQlRvTUoydXJ0TTdKUTZLOUZWMUU1N0RwNVB6UVVXQXdWLVNvYkNqRFVPNTNMaE1WeXFqekl1X1hsX19tN3lXTVRGY3I2V2FKRlR3RzBhVHhzYTJGM19RTHNGZkxZVEZvWlVlVTI3QUljWVgtUlpvUzBtenlfb1BtVldleEpMcXlkOGR6QnRmc3dXamxMWFVSeU5OZWpPa1lJbm85cHlMdlgtTWlpbHQtRXVYU0lyZ1ZfQzFzQmtILV9GWmNPY2o5ZktzaFJ2T1B0ejdzU0h4dzMweVhaN2RsQQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' (NASDAQ:VRTX) Performance Is Even Better Than Its Earnings Suggest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-11T11:45:24+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Cautious Optimism: Hold Rating on Vertex Pharmaceuticals Amid Promising Clinical Trial Data - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNdnpFd2Fib21nWktnTkYtUW5TRWdhTzhXRG1yM2hPRFU1b19fN3Q3OFBKZ1kwd3Jhc0puYmQ2cF9pWjJPYVl3eUdnSmJaLS1TckpGWlQ2Z0tzc2M2RnRsd1Q1Y2RZNzJ0ZkVQUWtYc3RtTVh5VTdYN3h6OWd6eDl1aXZxcF9jbFpJa2s4aXU3NVBOeWhVaW4xcF83SXp2b2Q2YXpnMlE2ckdtV3dpM0EwdjBDNTNiNFluNnhjYTlOMUw5YzZYQXhpcUxub1FHcFVhZXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNdnpFd2Fib21nWktnTkYtUW5TRWdhTzhXRG1yM2hPRFU1b19fN3Q3OFBKZ1kwd3Jhc0puYmQ2cF9pWjJPYVl3eUdnSmJaLS1TckpGWlQ2Z0tzc2M2RnRsd1Q1Y2RZNzJ0ZkVQUWtYc3RtTVh5VTdYN3h6OWd6eDl1aXZxcF9jbFpJa2s4aXU3NVBOeWhVaW4xcF83SXp2b2Q2YXpnMlE2ckdtV3dpM0EwdjBDNTNiNFluNnhjYTlOMUw5YzZYQXhpcUxub1FHcFVhZXc?oc=5\" target=\"_blank\">Cautious Optimism: Hold Rating on Vertex Pharmaceuticals Amid Promising Clinical Trial Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-10T09:46:57+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3 - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5\" target=\"_blank\">Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-12",
      "close": 434.19000244140625
    },
    "history": [
      {
        "date": "2025-11-04",
        "close": 421.6700134277344
      },
      {
        "date": "2025-11-05",
        "close": 417.0
      },
      {
        "date": "2025-11-06",
        "close": 416.25
      },
      {
        "date": "2025-11-07",
        "close": 409.4700012207031
      },
      {
        "date": "2025-11-10",
        "close": 421.20001220703125
      },
      {
        "date": "2025-11-11",
        "close": 429.2200012207031
      },
      {
        "date": "2025-11-12",
        "close": 434.19000244140625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}